BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 14533495)

  • 1. [Thrombosis prophylaxis in orthopaedic surgery: considerations and uncertainties].
    Ettema HB; Hoppener MR; Büller HR; Henny ChP; Verheyen CC
    Ned Tijdschr Geneeskd; 2003 Sep; 147(38):1842-7. PubMed ID: 14533495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
    Whang PG; Lieberman JR
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
    Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
    Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of D-dimer after total hip arthroplasty in patients with and without intraoperative heparin.
    Maezawa K; Nozawa M; Aritomi K; Kubota M; Shitoto K; Kurosawa H
    Arch Orthop Trauma Surg; 2008 Jan; 128(1):37-40. PubMed ID: 17522875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term cost-effectiveness of low molecular weight heparin versus unfractionated heparin for the prophylaxis of venous thromboembolism in elective hip replacement.
    Marchetti M; Liberato NL; Ruperto N; Barosi G
    Haematologica; 1999 Aug; 84(8):730-7. PubMed ID: 10458700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombosis prevention in orthopaedic surgery: clinical practice in the Netherlands in 2002].
    Schonenberg D; van Meeteren M; Nelissen RG; van der Horst-Bruinsma IE; Pöll RG; Nurmohamed MT
    Ned Tijdschr Geneeskd; 2003 Sep; 147(38):1856-60. PubMed ID: 14533499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of venous thromboembolism in high-risk surgical and medical patients.
    Prandoni P; Sabbion P; Tanduo C; Errigo G; Zanon E; Bernardi E
    Semin Vasc Med; 2001; 1(1):61-70. PubMed ID: 15199515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.
    Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep vein thrombosis prophylaxis: a comprehensive approach for total hip and total knee arthroplasty patient populations.
    Miric A; Lombardi P; Sculco TP
    Am J Orthop (Belle Mead NJ); 2000 Apr; 29(4):269-74. PubMed ID: 10784014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prophylaxis for deep vein thrombosis with low molecular weight heparin following hip and knee surgery].
    Li XL; Lu WJ; Yu NS
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Jan; 15(1):39-41. PubMed ID: 12563929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for low-molecular-weight heparin prophylaxis after total knee arthroplasty.
    Colwell CW; Hardwick ME
    Clin Orthop Relat Res; 2006 Nov; 452():181-5. PubMed ID: 17016231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of low molecular weight heparin in total knee arthroplasty.
    Iobst CA; Friedman RJ
    Am J Knee Surg; 1999; 12(1):55-60. PubMed ID: 10050695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of thromboprophylaxis in the management of total hip and knee arthroplasty.
    Skinner HB; Schulz MM
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):20-30. PubMed ID: 12349892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in DVT prophylaxis and management in major orthopaedic surgery.
    Hardwick ME; Colwell CW
    Surg Technol Int; 2004; 12():265-8. PubMed ID: 15455336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low molecular weight heparin for the prevention of deep vein thrombosis following orthopedic surgery.
    Lassen MR; Borris LC
    Curr Opin Pulm Med; 1996 Jul; 2(4):300-4. PubMed ID: 9363156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the risks and benefits of differing prophylaxis regimens for the treatment of deep venous thrombosis and pulmonary embolism in neurosurgery.
    Epstein NE
    Surg Neurol; 2005 Oct; 64(4):295-301; discussion 302. PubMed ID: 16181995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.